INADL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.732000E-01
Normal-vs-Stage2
4.395200E-01
Normal-vs-Stage3
4.460800E-01
Normal-vs-Stage4
1.658160E-01
Stage1-vs-Stage2
3.641600E-01
Stage1-vs-Stage3
1.948570E-01
Stage1-vs-Stage4
5.640200E-02
Stage2-vs-Stage3
7.567800E-02
Stage2-vs-Stage4
1.897790E-01
Stage3-vs-Stage4
3.088100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.464600E-01
Normal-vs-AfricanAmerican
4.409600E-01
Normal-vs-Asian
3.542400E-01
Caucasian-vs-AfricanAmerican
4.917000E-01
Caucasian-vs-Asian
2.848600E-01
AfricanAmerican-vs-Asian
8.032200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.339200E-01
Normal-vs-Female
6.238800E-01
Male-vs-Female
2.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.222800E-01
Normal-vs-Age(41-60Yrs)
3.055200E-01
Normal-vs-Age(61-80Yrs)
6.293400E-01
Normal-vs-Age(81-100Yrs)
9.829400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.602400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.928400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.234000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.485930E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.479600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.584000E-01
Normal-vs-Daily Drinker
6.349600E-01
Normal-vs-Weekly Drinker
6.846400E-01
Normal-vs-Occasional Drinker
1.581230E-01
Normal-vs-Social Drinker
2.111600E-01
Non Drinker-vs-Daily Drinker
9.454800E-01
Non Drinker-vs-Weekly Drinker
7.872400E-02
Non Drinker-vs-Occasional Drinker
1.231210E-01
Non Drinker-vs-Social Drinker
9.829000E-01
Daily Drinker-vs-Weekly Drinker
1.010400E-01
Daily Drinker-vs-Occasional Drinker
1.618590E-01
Daily Drinker-vs-Social Drinker
9.243600E-01
Weekly Drinker-vs-Occasional Drinker
1.698740E-03
Weekly Drinker-vs-Social Drinker
1.504080E-02
Occasional Drinker-vs-Social Drinker
6.431600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.803520E-02
Normal-vs-Grade 2
5.843700E-03
Normal-vs-Grade 3
2.437700E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.103540E-02
Grade 1-vs-Grade 3
6.19459999999794E-05
Grade 1-vs-Grade 4
1.803520E-02
Grade 2-vs-Grade 3
9.082000E-02
Grade 2-vs-Grade 4
5.843700E-03
Grade 3-vs-Grade 4
2.437700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.747400E-01
Normal-vs-NonDiabetic
4.765600E-01
Diabetic-vs-NonDiabetic
3.508200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.984000E-01
Normal-vs-NoPancreatitis
5.498400E-01
Pancreatitis-vs-NoPancreatitis
1.047230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.713600E-01
Normal-vs-N1
4.694200E-01
N0-vs-N1
4.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.011600E-02
Normal-vs-TP53-NonMutant
5.815600E-01
TP53-Mutant-vs-TP53-NonMutant
7.70850000000323E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
